Background and study aim: Interstitial lung disease (ILD) includes a variety group of about 200 conditions that insult the lung parenchyma with different patterns of inflammation and fibrosis. Hepatitis C virus (HCV)is Flavivirus with diverse hepatic and extrahepatic diseases. Its direct and indirect pathogenic association with many pulmonary manifestations-including interstitial lung disease-has been suggested yet needs more elucidation.
Patients and Methods:
A case control study was conducted with a total of 50 chronic hepatic patients. They were equally divided into two groups, HCV positive group (group 1= 25 patients) and HCV negative group (group 2= 25 patients). Group 1 was subdivided into two subgroups, without-idiopathic interstitial pneumonias patients (without IIPs subgroup A= 13 patients) and with idiopathic interstitial pneumonias patients (IIPs subgroup B = 12 patients). Both groups were subjected to thorough history taking, clinical examination, and routine investigations. The diagnosis of HCV was confirmed by viral markers including HCV antibodies and PCR. Other chronic hepatic liver diseases were confirmed by abdominal ultrasound and ultrasound-guided liver biopsy. Arterial blood gases, auto antibodies, Computerized pulmonary function tests and radiological studies including plain X ray chest and heart and HRCT scanning were also done. All patients with idiopathic pulmonary fibrosis (IPF) had fulfilled the ATS/ ERS diagnostic guidelines. Both groups were matched according to age, sex and body mass index. 
INTRODUCTION

PATIENTS AND METHODS
The study was conducted in Tropical Medicine and Chest Departments, Zagazig University Hospitals between May 2015 and May 2016.The study protocol was approved from the Ethical Committee of the university. A case control study was conducted with a total of 50 chronic hepatic patients. They were equally divided into two groups, HCV positive group (group 1= 25 patients) and HCV negative group (group 2 =25 patients). Group 1 was subdivided into two subgroups, without-idiopathic interstitial pneumonias patients (without IIPs subgroup A = 13 patients) and with idiopathic interstitial pneumonias patients (with IIPs subgroup B = 12 patients). Group 2 included patients with autoimmune hepatitis, hepatitis B virus infection (HBV) and non-alcoholic steatohepatitis (NASH). 
RESULTS
Fifty hepatic patients were included in this study. There were 44 % of HCV positive cases with low viremia while 56 % showed high viremia. Data about ILD from developing countries are lacking. In some countries the diagnosis of ILD can be mistaken with highly prevalent diseases such as tuberculosis which leads to fibrosis mimicking ILD. The Limited resources and poor socio-economic conditions adds to the problem [37]. This work aims at clarifying the exact relation between chronic HCV infection and ILD.
The study included 50 patients divided into 2 groups, chronic HCV positive (25 patients) and chronic HCV negative (25 patients) groups. Both groups were divided into age and sex groups without any significant difference in all demographic parameters.
Within HCV positive group, dyspnea and dyspnea score were found to be more in with IIPs patient than without IIPs patients and the difference was highly significant. However, Martinot-Peignoux et al. [26] found no clinical difference in HCV positive patients that can be attributed to the short duration of disease in their studied IPF patients with no chance to develop the full blown clinical picture of the pulmonary pathology.
Cirrhosis was delineated by the lower normal albumin level, low platelets count, minimal increase in bilirubin level and the more elevation of ALT than AST. Cirrhosis was excluded mainly by the liver biopsy.
Hypoxemia was more found among HCV positive group than HCV negative group and the difference was highly significant. This can be explained by the more prevalence of IPF among HCV positive group. IPF is involved in impairment of gas exchange and the eventual hypoxemia through chronic immune activation and inflammation induced by chronic HCV infection leading to decline in pulmonary functions. Our results coincide with those of Saleh et al.
[27] who documented HCV positive related cryoglobulinemia that can be involved in impaired gas exchange and air way parameters. Hypoxemia was also encountered in patients without IPF that can be explained by the diffuse pulmonary vascular dilatation and aneurysmal formation leading to ventilation perfusion mismatching and eventual impaired pulmonary gas exchange. The restrictive pattern of pulmonary functions was the more prevalent in HCV positive than HCV negative patients and the difference was highly significant. This result coincides with that of Elham et al.
[28] and can be explained in part by the ongoing interstitial pathology and also by the superadded polymyositis which is commonly encountered as a complication of chronic HCV infection. Polymyositis can impair the respiratory mechanism through weakening of respiratory muscles.
IPF cases were more prevalent among patients with high HCV viremia than other groups. Also, high viremia was more encountered in patients with IPP than without IPP and the difference was highly significant. This result agrees with that of Saleh et al. [27] who found an intimate relation between HCV viremia and the cryoglobulinemia involved in pulmonary interstitial pathology and the eventual impaired gas exchange. So, viremia may be implicated in IPF by directly pathogenic effect on lung parenchyma or indirectly through autoimmune mechanisms and cryoglobulinemia.
Our study showed that IIPs was more prevalent among HCV positive patients than HCV negative patients and the difference was highly significant. According to METAVIR score, IIP was found to be more prevalent among F3 group while without IIP was more prevalent among F2 group and the difference was highly significant. This result coincides with that of Elnady et al. [33] who found direct correlation between liver fibrosis stages and HRCT of the studied patients. This can be explained by the potential alveolitis induced by HCV with eventual pulmonary fibrosis.
Higher HRCT scores was found among HCV positive IIP patients than HCV negative IIP patients by semi-quantitative scoring and the difference was highly significant. This result agrees with that of Rabae et al. [34] who found that HRCT score was higher among HCV positive IPF patients than HCV negative IPF patients. This can be attributed to the increased reticular fibrosis and honey-combing extending into the lung lobules in HCV positive cases than HCV negative cases. This pulmonary pathology imitates that induced by HCV in the liver. This pathology is related to the HCV lymphotropism with subsequent immune activation and inflammation.
CONCLUSION
ILD was frequently encountered in patients with chronic HCV infection with higher grades of fibrosis and hypoxemia. HCV infection may be a predisposing factor for IPF.
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